Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $15.8300 (0.32%) ($15.5100 - $16.0500) on Thu. Jul. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.27% (three month average) | RSI | 70 | Latest Price | $15.8300(0.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.4% a day on average for past five trading days. | Weekly Trend | FOLD advances 2.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(54%) IWO(51%) XBI(50%) IWM(47%) IWC(45%) | Factors Impacting FOLD price | FOLD will decline at least -2.135% in a week (0% probabilities). VIXM(-28%) VXX(-14%) UUP(-12%) IYT(-5%) XLC(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.135% (StdDev 4.27%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
5 Day Moving Average | $15.73(0.64%) | 10 Day Moving Average | $15.59(1.54%) | 20 Day Moving Average | $14.6(8.42%) | To recent high | -0.4% | To recent low | 57.8% | Market Cap | $4.088b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |